PNC Financial Services Group
OTLK icon

PNC Financial Services Group’s Outlook Therapeutics OTLK Stock Holding History

PNC Financial Services Group’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.15K Buy
25,000
+10,000
+67% +$4.32K ﹤0.01% 4254
2025
Q4 		$23.7K Buy
15,000
+3,472
+30% +$5.55K ﹤0.01% 3587
2025
Q3 		$12.2K Sell
11,528
-629
-5% -$1.09K ﹤0.01% 3857
2025
Q2 		$19.5K Buy
12,157
+1,431
+13% +$2.28K ﹤0.01% 3585
2025
Q1 		$13.1K Buy
10,726
+726
+7% +$1.27K ﹤0.01% 3728
2024
Q4 		$18.9K Hold
10,000
– – ﹤0.01% 3555
2024
Q3 		$53.4K Buy
+10,000
New +$73.2K ﹤0.01% 3045
2024
Q1 		– Sell
-20
Closed -$160 – 4781
2023
Q4 		$160 Buy
+20
New +$169 ﹤0.01% 4500
2023
Q1 		– Sell
-10
Closed -$216 – 4783
2022
Q4 		$216 Buy
+10
New +$218 ﹤0.01% 4629

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

PNC Financial Services Group's OTLK Position: Q1 2026 in Review

PNC Financial Services Group increased its Outlook Therapeutics (OTLK) stake by 67% in Q1 2026, buying an estimated $4.32K and bringing the position to 25,000 shares worth $5.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

PNC Financial Services Group first reported a position in OTLK in Q4 2022 and has held it in 9 quarters since. The position peaked at $53.4K in Q3 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • PNC Financial Services Group held 25,000 shares of Outlook Therapeutics worth $5.15K as of Q1 2026.
  • PNC Financial Services Group bought 10,000 Outlook Therapeutics shares in Q1 2026, an estimated $4.32K.
  • Outlook Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4254 holding.
  • PNC Financial Services Group first reported a position in Outlook Therapeutics in Q4 2022 and has held it in 9 quarters since.
  • PNC Financial Services Group's Outlook Therapeutics position peaked at $53.4K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.